welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 465 blog entries.

Medicine Supply Notification: Naltrexone 50mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Naltrexone 50mg tablets MSN/2024/087 Tier 2 – medium impact Date of issue: 22nd August 2024 Naltrexone 50mg tablets (Accord) are in limited supply until early September 2024 and then out of stock until late October 2024. Naltrexone (Adepend®) 50mg tablets (AOP [...]

The post Medicine Supply Notification: Naltrexone 50mg tablets appeared first on Community Pharmacy England.

By |August 22nd, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Naltrexone 50mg tablets

Medicine Supply Notification: Methylphenidate prolonged-release tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Methylphenidate prolonged-release tablets MSN/2024/086 Tier 3 high impact Date of issue: 22nd August 2024 Methylphenidate prolonged-release tablet brands are in limited supply and intermittent regional supply disruptions are expected to continue until October 2024. Lisdexamfetamine (Elvanse®, Elvanse Adult®) capsules remain available [...]

The post Medicine Supply Notification: Methylphenidate prolonged-release tablets appeared first on Community Pharmacy England.

By |August 22nd, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Methylphenidate prolonged-release tablets

MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

Class 4 Medicines Defect Information: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Drug alert number: EL (24)A/39 Date issued: 19 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) Company name: Glenmark Pharmaceuticals Europe [...]

The post MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.

By |August 19th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fingolimod 0.5 mg Hard Capsules (Glenmark Pharmaceuticals Europe Ltd)

August 2024 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (16/08/2024) announced the following list of price concessions for August 2024: Drug Pack size Price concession Amiloride 5mg tablets 28 £15.70 Amisulpride 200mg tablets 60 £28.42 Bimatoprost 300micrograms/ml / [...]

The post August 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |August 16th, 2024|Lexpos News|Comments Off on August 2024 Price Concessions 1st Update

MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited)

Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Drug alert number: EL (24)A/37 Date issued: 14 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) Company [...]

The post MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited) appeared first on Community Pharmacy England.

By |August 14th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Trazodone Hydrochloride 50mg, 100mg Capsules & 50mg/5ml Oral Solution (Dawa Limited)